New ACS Guidelines Push for Earlier Prostate Cancer Screening

The American Cancer Society has updated its prostate cancer screening guidelines for the first time since 2010, recommending regular PSA testing for men aged 50 to 69. The new guidance emphasizes risk-based screening intervals, particularly for Black men and those with a family history of the disease.
Why it matters
Updated medical guidelines directly influence clinical practice and public health outcomes regarding cancer detection and mortality reduction.
The American Cancer Society (ACS) updated its prostate cancer screening guideline to recommend regular prostate-specific antigen (PSA)-based testing for men at average risk aged 50 to 69 years, with earlier and more frequent screening for men at increased risk. Published November 12, 2026, in CA: A Cancer Journal for Clinicians, the recommendations also outline additional testing strategies to guide biopsy decisions and reduce unnecessary procedures.1,2
The update is the first revision to the ACS prostate cancer screening guideline since 2010 and incorporates evidence supporting PSA-based screening to reduce prostate cancer mortality and advanced-stage diagnoses. The recommendations also account for advances in diagnostic testing and active surveillance intended to minimize harms associated with overdiagnosis and overtreatment.
ACS Recommends Risk-Based PSA Screening Intervals
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in